Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on January 11, 2021, to provide an update on its financial guidance for the full year 2020. This filing primarily consists of a press release detailing the revised financial outlook. While the specifics of the updated guidance are contained within the attached press release (Exhibit 99.1), the 8-K itself signals a material event related to the company's financial performance expectations. Investors should note that Gilead presents financial information on both a GAAP and a non-GAAP basis. The company's management views non-GAAP measures as useful for understanding operational performance, budgeting, and financial planning. A reconciliation between GAAP and non-GAAP figures is provided in the press release, allowing investors to compare both perspectives. It is important for investors to understand that non-GAAP measures are not standardized across all companies and should be used to supplement, not replace, the analysis of GAAP-reported results.
Key Highlights
- 1Gilead Sciences updated its financial guidance for the full year 2020 via a press release filed with the 8-K.
- 2The press release (Exhibit 99.1) is the primary source of detailed financial guidance information.
- 3The company provided both GAAP and non-GAAP financial information in its guidance update.
- 4Management believes non-GAAP financial information offers useful insights for operational and strategic planning.
- 5A reconciliation between GAAP and non-GAAP financial measures is available in the accompanying press release.
- 6The information provided is not deemed 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.